ArticleFrontiers in health services2025
Improving access to healthcare services for sickle cell disease patients in Nigeria: perspectives and views of healthcare professionals.
Article in Frontiers in health services, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analgesic Utilization Pattern and Cost of Managing Children with Sickle Cell Diseases: a Retrospective Single-site Audit.Journal of racial and ethnic health disparities · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: In sub-Saharan Africa, the burden of sickle cell disease remains high. With annual sickle cell births of about 150,000, Nigeria is reported to have the highest prevalence of the disease globally. This study aimed to explore the views and perspectives of healthcare professionals regarding access to healthcare services for sickle cell disease. Methods: A quantitative cross-sectional design was employed for this study. Participants comprised healthcare practitioners across Nigeria. A well-structured questionnaire was utilised for data collection. A stratified multistage sampling strategy was used for the study, and respondents were recruited from all the six geographical zones in the country. Data collected were entered into Statistical Package for Social Sciences (SPSS) software version 25. Descriptive and inferential statistical analyses were undertaken. Results were presented in frequencies and percentages. Results: The response rate was 83.5% (1,002/1,200); male and female participants were of similar proportions, as indicated by 51.2% and 48.8%, respectively. A significant proportion of the participants (43.1%) disagreed that development partners have adequately contributed to the funding of sickle cell disease research in Nigeria. The majority of the respondents (81%) indicated that providing special funding for health research can facilitate access to healthcare services for sickle cell patients, whilst a similar proportion (79.2%) disagreed that the government alone bears the responsibility for healthcare initiatives for the disease. A third of the study participants (67.8%) were of the view that current research and development efforts towards sickle cell disease were inadequate. Conclusion: This study describes health professionals' views on access to healthcare for sickle cell, and the findings revealed the criticality of private and development sector funding in reducing the burden of the disease. Furthermore, capacity building at the primary healthcare level would not only ensure access to the basic healthcare needs of patients but could also demystify the condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.